PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.49%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.01%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-1.42%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
0.44%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
-4.70%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-4.35%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-4.35%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.46%
Share reduction while ADI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.54%
Reduced diluted shares while ADI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.15%
Dividend growth above 1.5x ADI's 0.08%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-61.47%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-64.74%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
62.88%
10Y revenue/share CAGR above 1.5x ADI's 23.64%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
68.66%
5Y revenue/share CAGR above 1.5x ADI's 22.92%. David Dodd would look for consistent product or market expansions fueling outperformance.
-5.06%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
88.46%
Positive long-term OCF/share growth while ADI is negative. John Neff would see a structural advantage in sustained cash generation.
117.10%
5Y OCF/share CAGR at 75-90% of ADI's 145.09%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
-3.34%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
112.73%
Net income/share CAGR above 1.5x ADI's 55.59% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
3278.82%
5Y net income/share CAGR above 1.5x ADI's 470.27%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-21.06%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
40.88%
10Y equity/share CAGR at 50-75% of ADI's 66.19%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
36.00%
Below 50% of ADI's 86.16%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
8.43%
Below 50% of ADI's 36.57%. Michael Burry suspects a serious short-term disadvantage in building book value.
1308.17%
10Y dividend/share CAGR above 1.5x ADI's 749.52%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
171.86%
5Y dividend/share CAGR above 1.5x ADI's 69.75%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
129.32%
3Y dividend/share CAGR above 1.5x ADI's 54.36%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
12.64%
AR growth well above ADI's 1.12%. Michael Burry fears inflated revenue or higher default risk in the near future.
-0.98%
Inventory is declining while ADI stands at 2.33%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.02%
Negative asset growth while ADI invests at 0.28%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.28%
We have a declining book value while ADI shows 1.18%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
9.58%
Debt growth far above ADI's 0.02%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
5.78%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
3.90%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.